Furthermore, STAT6D419 mutant tumor cells secrete more of the chemokine CCL17 upon IL-4 stimulation, and we are the first to provide evidence that this leads to increased CD4+ T-cell infiltration in rrDLBCL patient tumor biopsies. This evidence concerns the gene CCL17 and neoplasm.